NVNO (enVVeno Medical) Total Liabilities: $2.35 Mil (As of Mar. 2026)


NVNO enVVeno Medical Corp NVNO
26 GF Score
Price $11.10
! 3 Warning Signs
View Full Analysis

What is enVVeno Medical Total Liabilities?

enVVeno Medical NVNO -0.09% 26 Total Liabilities is $2.35 Mil as of Mar. 2026. GuruFocus rates NVNO with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

enVVeno Medical's Total Liabilities for the quarter that ended in Mar. 2026 was $2.35 Mil.

enVVeno Medical's quarterly Total Liabilities declined from Sep. 2025 ($2.91 Mil) to Dec. 2025 ($2.43 Mil) and declined from Dec. 2025 ($2.43 Mil) to Mar. 2026 ($2.35 Mil).

enVVeno Medical's annual Total Liabilities increased from Dec. 2023 ($2.44 Mil) to Dec. 2024 ($2.80 Mil) but then declined from Dec. 2024 ($2.80 Mil) to Dec. 2025 ($2.43 Mil).

enVVeno Medical Total Liabilities Historical Data

* Premium members only.

The historical data trend for enVVeno Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

enVVeno Medical Total Liabilities Chart

enVVeno Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.30 2.93 2.44 2.80 2.43

enVVeno Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.27 3.52 2.91 2.43 2.35
NVNO
26GF Score
enVVeno Medical Corp NVNO
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

enVVeno Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

enVVeno Medical's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.122+(0.31+5.5511151231258E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.43

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=29.562-27.13
=2.43

enVVeno Medical's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.143+(0.207+3.0531133177192E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.35

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=26.097-23.747
=2.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $2.35 Mil mean?
enVVeno Medical (NVNO) has a Total Liabilities of $2.35 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for enVVeno Medical and its competitors.
Is enVVeno Medical's Total Liabilities too high?
enVVeno Medical's current Total Liabilities is $2.35 Mil. Overall, enVVeno Medical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does enVVeno Medical's Total Liabilities compare to STME and TRIB?
enVVeno Medical's Total Liabilities of $2.35 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for enVVeno Medical and its competitors. enVVeno Medical's current Total Liabilities is $2.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is enVVeno Medical stock overvalued right now?
enVVeno Medical (NVNO) has a current Total Liabilities of $2.35 Mil. The current Total Liabilities is $2.35 Mil. enVVeno Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For enVVeno Medical (NVNO), the current Total Liabilities is $2.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

enVVeno Medical Business Description

Address 70 Doppler, Irvine, CA, USA, 92618
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
26GF Score

Get the complete analysis for NVNO

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.10
Price